Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction

Inclusion Criteria (subjects must): * Be ≥ 60 years of age * Have a corrected visual acuity of LogMAR +0.5 (ETDRS) * Have a documented history of Meibomian Gland Dysfunction * Have a TFBUT ≤ 5 seconds * Have an ocular discomfort score ≥ 1 * Have an IOP ≤ 25 mmHg at Visit 1 in both eyes * Report use of and/or desire to use an artificial tears Exclusion Criteria (subjects may not): * Have contraindications to the use of the study medications * Have a known allergy or sensitivity to the study medications * Have any ocular infections, or active ocular inflammation * Have used ocular medications within 24 hours prior to Visit 1 * Be a current contact lens wearer * Require the use of any other ophthalmic medication, other than tear substitutes and study medication provided, for the duration of the trial * Have used systemic or topical antihistamines or steroids 48 hours prior to Visit 1 or require the use of systemic or topical antihistamines or steroids during the course of the study * Have a history of prostate cancer